A molecular taxonomy for urothelial carcinoma G Sjödahl, M Lauss, K Lövgren, G Chebil, S Gudjonsson, S Veerla, ... Clinical cancer research 18 (12), 3377-3386, 2012 | 929 | 2012 |
Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome D Lindgren, A Frigyesi, S Gudjonsson, G Sjödahl, C Hallden, G Chebil, ... Cancer research 70 (9), 3463-3472, 2010 | 335 | 2010 |
MiRNA expression in urothelial carcinomas: important roles of miR‐10a, miR‐222, miR‐125b, miR‐7 and miR‐452 for tumor stage and metastasis, and frequent homozygous losses of miR‐31 S Veerla, D Lindgren, A Kvist, A Frigyesi, J Staaf, H Persson, F Liedberg, ... International journal of cancer 124 (9), 2236-2242, 2009 | 306 | 2009 |
STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer C Pena, MV Céspedes, MB Lindh, S Kiflemariam, A Mezheyeuski, ... Cancer research 73 (4), 1287-1297, 2013 | 211 | 2013 |
Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors M Heidenblad, D Lindgren, T Jonson, F Liedberg, S Veerla, G Chebil, ... BMC medical genomics 1, 1-12, 2008 | 116 | 2008 |
Independent component analysis reveals new and biologically significant structures in micro array data A Frigyesi, S Veerla, D Lindgren, M Höglund BMC bioinformatics 7, 1-12, 2006 | 106 | 2006 |
The DNA methylome of pediatric acute lymphoblastic leukemia J Davidsson, H Lilljebjörn, A Andersson, S Veerla, J Heldrup, ... Human molecular genetics 18 (21), 4054-4065, 2009 | 103 | 2009 |
Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial M Feldt, O Bjarnadottir, S Kimbung, K Jirström, PO Bendahl, S Veerla, ... Journal of translational medicine 13, 1-11, 2015 | 93 | 2015 |
Cell-type-specific gene programs of the normal human nephron define kidney cancer subtypes D Lindgren, P Eriksson, K Krawczyk, H Nilsson, J Hansson, S Veerla, ... Cell reports 20 (6), 1476-1489, 2017 | 92 | 2017 |
Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems P Eriksson, M Aine, S Veerla, F Liedberg, G Sjödahl, M Höglund BMC medical genomics 8, 1-15, 2015 | 85 | 2015 |
FUS-CREB3L2/L1–positive sarcomas show a specific gene expression profile with upregulation of CD24 and FOXL1 E Möller, JL Hornick, L Magnusson, S Veerla, HA Domanski, F Mertens Clinical Cancer Research 17 (9), 2646-2656, 2011 | 82 | 2011 |
Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling O Frings, M Augsten, NP Tobin, J Carlson, J Paulsson, C Pena, E Olsson, ... The American journal of pathology 182 (6), 2037-2047, 2013 | 76 | 2013 |
Global transcriptional changes following statin treatment in breast cancer O Bjarnadottir, S Kimbung, I Johansson, S Veerla, M Jönsson, ... Clinical Cancer Research 21 (15), 3402-3411, 2015 | 65 | 2015 |
Analysis of promoter regions of co-expressed genes identified by microarray analysis S Veerla, M Höglund BMC bioinformatics 7, 1-15, 2006 | 65 | 2006 |
Gene expression profiling of large cell lung cancer links transcriptional phenotypes to the new histological WHO 2015 classification A Karlsson, H Brunnström, P Micke, S Veerla, J Mattsson, L La Fleur, ... Journal of Thoracic Oncology 12 (8), 1257-1267, 2017 | 58 | 2017 |
DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status M Lauss, M Aine, G Sjödahl, S Veerla, O Patschan, S Gudjonsson, ... Epigenetics 7 (8), 858-867, 2012 | 57 | 2012 |
Transcriptional profiling of breast cancer metastases identifies liver metastasis–selective genes associated with adverse outcome in luminal a primary breast cancer S Kimbung, I Johansson, A Danielsson, S Veerla, S Egyhazi Brage, ... Clinical cancer research 22 (1), 146-157, 2016 | 50 | 2016 |
Genome-wide transcription factor binding site/promoter databases for the analysis of gene sets and co-occurrence of transcription factor binding motifs S Veerla, M Ringnér, M Höglund BMC genomics 11, 1-17, 2010 | 47 | 2010 |
Promoter analysis of epigenetically controlled genes in bladder cancer S Veerla, I Panagopoulos, Y Jin, D Lindgren, M Höglund Genes, Chromosomes and Cancer 47 (5), 368-378, 2008 | 46 | 2008 |
Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma M Aine, G Sjödahl, P Eriksson, S Veerla, D Lindgren, M Ringnér, ... Genome medicine 7, 1-20, 2015 | 43 | 2015 |